搜尋
Immunoprecise Antibodies Ltd
IPA添加自選
2.070USD
0.0000.00%
收盤 07/02, 13:00（美東）報價延遲15分鐘
95.54M總市值
虧損本益比TTM
關於 Immunoprecise Antibodies Ltd 公司
ImmunoPrecise Antibodies Ltd. 是一家生物技術公司，通過一系列專有和專利技術利用多組學建模和複雜人工智能。該公司擁有一套集成的端到端功能來支持治療性抗體的開發。它在北美和歐洲擁有多家子公司，包括 Talem Therapeutics LLC、BioStrand BV、ImmunoPrecise Antibodies (Canada) Ltd. 和 ImmunoPrecise Antibodies (Europe) BV（統稱爲 IPA 家族）等實體。其合同研究組織 (CRO) 服務包括 B 細胞選擇；噬菌體展示；DeepDisplay；Abthena 雙特異性；LucinaTech 人性化；親和力成熟；免疫、雜交瘤、測序；rPEx 蛋白質製造和細胞系開發。該公司利用定製抗原建模、使用自然語言處理的靶標分析和 HYFTTM 分析爲後續實驗階段奠定基礎。
Immunoprecise Antibodies Ltd簡介
公司代碼IPA
公司名稱Immunoprecise Antibodies Ltd
上市日期Jan 30, 1987
CEODr. Jennifer Lynne Bath, Ph.D.
員工數量- -
證券類型Ordinary Share
年結日Jan 30
公司地址Industrious 823 Congress Ave Suite 300
城市AUSTIN
上市交易所NASDAQ Capital Market Consolidated
國家United States of America
郵編78701
電話16048060626
網址https://www.ipatherapeutics.com/
公司代碼IPA
上市日期Jan 30, 1987
CEODr. Jennifer Lynne Bath, Ph.D.
Immunoprecise Antibodies Ltd公司高管
名稱
名稱/職務
職務
持股
持股變動
Dr. Jennifer Lynne Bath, Ph.D.
Dr. Jennifer Lynne Bath, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
498.12K
--
Dr. Kamil Isaev
Dr. Kamil Isaev
Independent Director
Independent Director
3.19K
--
Mr. Dirk Witters
Mr. Dirk Witters
Independent Director
Independent Director
1.95K
--
Ms. Kari Graber
Ms. Kari Graber
Vice President - Commercial Services
Vice President - Commercial Services
700.00
--
Mr. Jonathan I. (Jon) Lieber
Mr. Jonathan I. (Jon) Lieber
Director
Director
--
--
Mr. Joseph Scheffler
Mr. Joseph Scheffler
Interim Chief Financial Officer
Interim Chief Financial Officer
--
--
Dr. Shuji Sato
Dr. Shuji Sato
Vice President - Innovative Solutions
Vice President - Innovative Solutions
--
--
名稱
名稱/職務
職務
持股
持股變動
Dr. Jennifer Lynne Bath, Ph.D.
Dr. Jennifer Lynne Bath, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
498.12K
--
Dr. Kamil Isaev
Dr. Kamil Isaev
Independent Director
Independent Director
3.19K
--
Mr. Dirk Witters
Mr. Dirk Witters
Independent Director
Independent Director
1.95K
--
Ms. Kari Graber
Ms. Kari Graber
Vice President - Commercial Services
Vice President - Commercial Services
700.00
--
Mr. Jonathan I. (Jon) Lieber
Mr. Jonathan I. (Jon) Lieber
Director
Director
--
--
Mr. Joseph Scheffler
Mr. Joseph Scheffler
Interim Chief Financial Officer
Interim Chief Financial Officer
--
--
常見問題
Immunoprecise Antibodies Ltd的前五大股東是誰？
Immunoprecise Antibodies Ltd的前五大股東如下：Dr. Jennifer Lynne Bath, Ph.D.
有多少機構持有Immunoprecise Antibodies Ltd(IPA)的股份？
截至2026Q1，共有47家機構持有Immunoprecise Antibodies Ltd的股份，合計持有的股份價值約為4.54M，占公司總股份的9.73% 。與2025Q4相比，機構持股有所增加，增幅為212280.00。
哪個業務部門對Immunoprecise Antibodies Ltd的收入貢獻最大？
在2026Q1，Project revenue業務部門對Immunoprecise Antibodies Ltd的收入貢獻最大，創收4.11M，占總收入的98.85% 。